Literature DB >> 12352158

Pharmacokinetic interaction between lopinavir/r and amprenavir in salvage therapy.

Stéphanie Basso, Caroline Solas, Anne-Marie Quinson, Isabelle Ravaux, Isabelle Poizot-Martin, J Bacconier, Alain Durand, Bruno Lacarelle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12352158     DOI： 10.1097/00126334-200209010-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  5 in total

Review 1.  Pharmacokinetic enhancement of protease inhibitor therapy.

Authors:  Jennifer R King; Heather Wynn; Richard Brundage; Edward P Acosta
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  Drug interactions with antiretrovirals.

Authors:  Linda M Catanzaro; Judianne C Slish; Robert DiCenzo; Gene D Morse
Journal:  Curr HIV/AIDS Rep       Date:  2004-06       Impact factor: 5.071

Review 3.  Double-boosted protease inhibitor antiretroviral regimens: what role?

Authors:  Esteban Ribera; Adrian Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Management of HIV-infected patients with multidrug-resistant virus.

Authors:  Marianne Harris; Julio S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

Review 5.  Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.

Authors:  Cédric Arvieux; Olivier Tribut
Journal:  Drugs       Date:  2005       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.